Amryt Pharma plc logo
Amryt Pharma plc AMYT

Geschäftsbericht 2021
hinzugefügt 23.12.2023

report update icon

Amryt Pharma plc Langfristiger Schuldenstrom 2011-2026 | AMYT

Langfristiger Schuldenstrom Jährlich Amryt Pharma plc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.54 M 963 K 571 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.54 M 571 K 1.03 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.38 3.53 % $ 340 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 336.1 -0.98 % $ 44 B usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.73 3.04 % $ 8.97 B australiaAustralia
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.2 4.92 % $ 5.27 M israelIsrael
Aligos Therapeutics Aligos Therapeutics
ALGS
3.58 M $ 7.21 -17.51 % $ 71.3 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 21.43 0.23 % $ 1 B usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 99.97 1.59 % $ 27.2 B germanyGermany
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.55 -0.96 % $ 399 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.22 1.57 % $ 451 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.84 -1.0 % $ 3.16 B usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.47 -0.68 % $ 391 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Baudax Bio Baudax Bio
BXRX
5.6 M - 0.59 % $ 63 K usaUSA